Director at OvaScience Inc. (NASDAQ:OVAS) F. Harald Stock recently acquired 1,063 shares of common stock, at a price of $7…
Browsing: BioTech
St. Jude Medical, Inc. (NYSE:STJ)’s Directors W John Brown, R Richard Devenuti and K Stefan Widensohler newly received stock awards…
President & Ceo at RXi Pharmaceuticals Corp (NASDAQ:RXII) Geert Cauwenbergh has acquired 2,000 shares of common stock, $0.0001 par value,…
Agenus Inc (NASDAQ:AGEN)’s Chairman & Ceo H Garo Armen procured 4,886 shares of Common Stock at a price of $2.7…
Uroplasty, Inc. (NASDAQ:UPI)’s director, Kevin H Roche, recently declared a new position in its stock with 10,000 shares common stock. He…
John Abrams Sr. Vp, Global Sales at MKS Instruments, Inc. (NASDAQ:MKSI), has acquired 433 shares of Common Stock. The stock…
Billionaire hedge fund manager Larry Robbins loves hospital, insurance and pharma stocks. Minutes ago Glenview Capital disclosed a 8.5% stake…
Wednesday, Thursday and Friday last week saw John Paulson’s Paulson & Co increase its stakes in Mallinckrodt PLC (NYSE:MNK) by…
Managed by John A. Levin, Levin Capital Strategies increased its holding in Bio-Rad Laboratories, Inc. (NYSE:BIO). The current position amounts…
Neal C. Bradsher’s Broadwood Capital has raised its stake in BioTime, Inc. (NYSEMKT:BTX), a recent Form 4 filing with the Securities and Exchange…
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked.…
Peter Kolchinsky’s Ra Capital Management considerably boosted its stake in Dyax Corp. (NASDAQ:DYAX), a recent 13G filing with the SEC shows. The…